In addition to the French data previously referred to on this site, data from another, much larger cohort of men treated with focal, high-intensity focused ultrasound (focal HIFU) are also to be presented at the upcoming annual meeting of the American Urological Association. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: focal, hemiablation, HIFU, intermediate risk, outcome, side effect | 4 Comments »
A major plenary presentation at the upcoming annual meeting of the American Urological Association (AUA) will provide data from a rather small French trial of high-intensity focused ultrasound (HIFU) in the focal management of localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: ablation, focal, hemiablation, HIFU, high-intensity, outcome, ultrasound | Leave a comment »
According to information released to the media on January 4 this year (which we have only now had brought to our attention) a combination of drug therapy with laser ablation has been approved “for the focal treatment of early stage prostate cancer.” … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, hemiablation, outcome, therapy, TOOKAD, VTP | 3 Comments »
A new report provides data from a prospective, single-center, Phase II trial of high-intensity focused ultrasound (HIFU) in prostate cancer hemiablation as a form of focal therapy. The study was carried out in Belgium. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: focal, focused, hemiablation, HIFU, high-intensity, outcome, Treatment, ultrasound | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 